BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12727953)

  • 21. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men.
    Van Pottelbergh I; Lumbroso S; Goemaere S; Sultan C; Kaufman JM
    Clin Endocrinol (Oxf); 2001 Nov; 55(5):659-66. PubMed ID: 11894978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls.
    Behre HM; Bohmeyer J; Nieschlag E
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):341-9. PubMed ID: 7514512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of androgen deficiency and replacement on prostate zonal volumes.
    Jin B; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system.
    Meikle AW; Arver S; Dobs AS; Adolfsson J; Sanders SW; Middleton RG; Stephenson RA; Hoover DR; Rajaram L; Mazer NA
    Urology; 1997 Feb; 49(2):191-6. PubMed ID: 9037280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
    Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.
    Stanworth RD; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2008 Dec; 159(6):739-46. PubMed ID: 18805913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
    Jockenhövel F; Blum WF; Vogel E; Englaro P; Müller-Wieland D; Reinwein D; Rascher W; Krone W
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2510-3. PubMed ID: 9253326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.
    Ferlin A; Schipilliti M; Vinanzi C; Garolla A; Di Mambro A; Selice R; Lenzi A; Foresta C
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E739-45. PubMed ID: 21270324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men?
    Lapauw B; Goemaere S; Crabbe P; Kaufman JM; Ruige JB
    Eur J Endocrinol; 2007 Mar; 156(3):395-401. PubMed ID: 17322500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men.
    Dobs AS; Meikle AW; Arver S; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3469-78. PubMed ID: 10522982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism.
    Schubert M; Minnemann T; Hübler D; Rouskova D; Christoph A; Oettel M; Ernst M; Mellinger U; Krone W; Jockenhövel F
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5429-34. PubMed ID: 15531493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study.
    Rolf C; von Eckardstein S; Koken U; Nieschlag E
    Eur J Endocrinol; 2002 Apr; 146(4):505-11. PubMed ID: 11916618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men.
    Behre HM; Kliesch S; Leifke E; Link TM; Nieschlag E
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2386-90. PubMed ID: 9253305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.
    Behre HM; von Eckardstein S; Kliesch S; Nieschlag E
    Clin Endocrinol (Oxf); 1999 May; 50(5):629-35. PubMed ID: 10468929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.
    Stanworth RD; Kapoor D; Channer KS; Jones TH
    Clin Endocrinol (Oxf); 2011 May; 74(5):624-30. PubMed ID: 21470285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men.
    Zitzmann M; Cremers JF; Krallmann C; Kliesch S
    Aging Male; 2022 Dec; 25(1):134-144. PubMed ID: 35467476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of androgen receptor CAG repeat polymorphism on andropausal symptoms in different serum testosterone levels.
    Liu CC; Lee YC; Wang CJ; Yeh HC; Li WM; Wu WJ; Huang CN; Bao BY; Huang CH; Huang SP
    J Sex Med; 2012 Sep; 9(9):2429-37. PubMed ID: 22429282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
    Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
    J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.